Table 1.
Participant characteristics.
| ImpRes | AerRes | DelAer | p value | |
|---|---|---|---|---|
| (n = 49) | (n = 50) | (n = 36) | ||
| Age, yr (SD) | 68.7 ± 9.3 | 69.1 ± 9.6 | 69.7 ± 8.4 | 0.869 |
| Height, cm (SD) | 173.5 ± 5.8 | 173.1 ± 6.7 | 171.9 ± 5.4 | 0.467 |
| Weight, kg (SD) | 84.5 ± 11.5 | 85.0 ± 16.0 | 87.6 ± 14.4 | 0.565 |
| Body fat, % (SD) | 27.7 ± 4.8 | 27.5 ± 6.1 | 29.1 ± 4.5 | 0.350 |
| Employed, N (%) | 22 (38.6) | 17 (31.5) | 19 (38.8) | 0.571 |
| Married, N (%) | 44 (77.2) | 42 (77.8) | 43 (87.8) | 0.720 |
| Current smoker, N (%) | 3 (5.3) | 3 (5.6) | 3 (6.1) | 0.822 |
| Gleason scorea | 7.0 (7.0–8.3) | 8.0 (7.0–9.0) | 7.0 (7.0–8.3) | 0.411 |
| ADT time, monthsa | 3.0 (2.0–4.5) | 3.0 (2.0–4.3) | 3.0 (2.0–4.0) | 0.624 |
| PSA, ng/mLa | 0.4 (0.1–1.2) | 0.2 (0.0–1.0) | 0.4 (0.0–1.0) | 0.599 |
| Testosterone, pg/mLa | 0.0 (0.0–1.3) | 0.8 (0.0–1.1) | 0.5 (0.0–0.9) | 0.973 |
| Other Conditions, N (%) | ||||
| Cardiovascular disease | 3 (6.1) | 3 (6.0) | 2 (5.6) | 0.994 |
| Hypertension | 17 (34.7) | 15 (30.0) | 19 (52.8) | 0.085 |
| Dyslipidemia | 9 (18.4) | 13 (26.0) | 9 (25.0) | 0.626 |
| Diabetes | 3 (6.1) | 7 (14.0) | 7 (19.4) | 0.175 |
ImpRes impact plus resistance exercise; AerRes aerobic plus resistance exercise; DelAer delayed followed by aerobic exercise; SD standard deviation; PSA prostate specific antigen.
aMedian and interquartile range (IQR); missing vales: employed n = 5, married n = 5, smoker n = 3, PSA n = 5, testosterone n = 6, Gleason score n = 14.